← Leaderboards
Marilyn Huestis
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectCocaineClinical ResearchNicotineDrug AbuseHeroinCannabinoidsPharmacokineticsCannabisMethamphetamineSmokingPlasmaHuman TissueUrineHairSweatBlood ChemistryPharmaceutical PreparationsInhalation Drug AdministrationBody FluidsSalivaDrug Administration RoutesSkinDose
Grant awards (47)
Monitoring In Utero Drug Exposure$651,649
Z01 · FY2008 · DA · contact PI
Assessment Of A Cannabinoid Antagonist In Humans$488,737
Z01 · FY2008 · DA · contact PI
Detection Of Drugs Of Abuse In Alternative Biological Fluids And Tissues$325,824
Z01 · FY2008 · DA · contact PI
Assessment Of A Cannabinoid Antagonist In Humans$630,065
Z01 · FY2007 · DA · contact PI
Detection Of Drugs Of Abuse In Alternative Biological Fluids And Tissues$630,065
Z01 · FY2007 · DA · contact PI
Monitoring In Utero Drug Exposure$630,065
Z01 · FY2007 · DA · contact PI
Effects of Sativex and Oral THC on Attention, Affect, Working Memory, Reversal Le$546,057
Z01 · FY2007 · DA · contact PI
Role of multidrug resistance protein 1a (MDR1a) in methamphetamine and methylened$420,044
Z01 · FY2007 · DA · contact PI
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse$420,044
Z01 · FY2007 · DA · contact PI
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$210,022
Z01 · FY2007 · DA · contact PI
Monitoring In Utero Drug Exposure$0
Z01 · FY2006 · DA · contact PI
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2006 · DA · contact PI
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of$0
Z01 · FY2006 · DA · contact PI
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2006 · DA · contact PI
Detection Of Drugs Of Abuse In Alternative Biological Fl$0
Z01 · FY2006 · DA · contact PI
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2005 · DA
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2005 · DA
Detection Of Abused Drugs In Biological Fluids &Tissues$0
Z01 · FY2005 · DA
Monitoring In Utero Drug Exposure$0
Z01 · FY2005 · DA
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs$0
Z01 · FY2005 · DA
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2004 · DA
Monitoring In Utero Drug Exposure$0
Z01 · FY2004 · DA
Smoked Drugs Of Abuse: Pharmacokinetics/Pharmacodynamics$0
Z01 · FY2004 · DA
Detection Of Drugs Of Abuse In Biological Fluids/Tissues$0
Z01 · FY2004 · DA
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2004 · DA
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of$0
Z01 · FY2003 · DA
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2003 · DA
Detection Of Drugs Of Abuse In Alternative Biological Fl$0
Z01 · FY2003 · DA
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2003 · DA
Monitoring In Utero Drug Exposure$0
Z01 · FY2003 · DA
Monitoring In Utero Drug Exposure$0
Z01 · FY2002 · DA
Detection Of Drugs Of Abuse In Alternative Biological Fl$0
Z01 · FY2002 · DA
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of$0
Z01 · FY2002 · DA
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2002 · DA
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2002 · DA
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse$0
Z01 · FY2001 · DA
Monitoring In Utero Drug Exposure$0
Z01 · FY2001 · DA
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs$0
Z01 · FY2001 · DA
Pharmacokinetics Of Cocaine in Chronic Users$0
Z01 · FY2001 · DA
Nicotine Patch/Gum For Treatment Of Nicotine Dependence$0
Z01 · FY2001 · DA
Assessment Of A Cannabinoid Antagonist In Humans$0
Z01 · FY2001 · DA
Detection Of Drugs Of Abuse In Biological Fluids$0
Z01 · FY2001 · DA
ASSESSMENT OF A CANNABINOID ANTAGONIST IN HUMANS$0
Z01 · FY2000 · DA
DETECTION OF DRUGS OF ABUSE IN ALTERNATIVE BIOLOGICAL FLUIDS AND TISSUES$0
Z01 · FY2000 · DA
PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUGS OF ABUSE$0
Z01 · FY2000 · DA
PHARMACOKINETICS AND PHARMACODYNAMICS OF SMOKED DRUGS OF ABUSE$0
Z01 · FY2000 · DA
Monitoring in utero drug exposure$0
Z01 · FY2000 · DA